​

Fulgent Genetics (FLGT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FLGT Stock Forecast

Fulgent Genetics (FLGT) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $45.00, with a high of $50.00 and a low of $40.00. This represents a 167.06% increase from the last price of $16.85.

$15 $22 $29 $36 $43 $50 High: $50 Avg: $45 Low: $40 Last Closed Price: $16.85

FLGT Stock Rating

Fulgent Genetics stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (50.00%), 1 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 1 1 Strong Sell Sell Hold Buy Strong Buy

FLGT Forecast vs Benchmarks

TypeNameUpside
StockFulgent Genetics167.06%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$16.85$16.85$16.85
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 251-2--3
Dec, 241-2--3
Nov, 24122--5
Oct, 24122--5
Sep, 24122--5
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 08, 2022Piper Sandler$40.00$37.077.90%137.39%
Nov 18, 2022Raymond James$45.00$35.8925.38%167.06%
Nov 14, 2022Credit Suisse$50.00$39.2427.42%196.74%
May 15, 2022David WestenbergPiper Sandler$70.00$54.4528.56%315.43%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Dec 08, 2022Piper SandlerOverweightNeutraldowngrade
Nov 18, 2022Raymond JamesOutperforminitialise
Nov 14, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-10 $-4 $2 $8 $14 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$9.44$17.25$4.76$-5.63---
Avg Forecast$6.26$15.68$5.61$-0.98$0.33$-0.15$0.03
High Forecast$6.08$15.24$5.43$-1.05$0.30$-0.77$0.03
Low Forecast$6.48$16.23$5.83$-0.91$0.35$0.46$0.03
Surprise %50.80%10.01%-15.15%474.49%---

Revenue Forecast

$250M $400M $550M $700M $850M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$421.71M$992.58M$618.97M$289.21M---
Avg Forecast$326.19M$933.03M$610.81M$278.40M$281.98M$324.65M$365.32M
High Forecast$319.09M$912.73M$595.77M$278.35M$279.61M$312.97M$365.05M
Low Forecast$334.97M$958.17M$629.02M$278.43M$284.35M$336.32M$365.59M
Surprise %29.29%6.38%1.34%3.89%---

Net Income Forecast

$-250M $-80M $90M $260M $430M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$214.31M$507.36M$143.40M$-167.82M---
Avg Forecast$186.38M$460.60M$336.61M$-167.82M$9.55M$-4.58M$784.00K
High Forecast$181.11M$368.48M$269.29M$-201.39M$8.81M$-22.92M$747.88K
Low Forecast$192.91M$552.73M$403.94M$-134.26M$10.28M$13.75M$820.12K
Surprise %14.98%10.15%-57.40%----

FLGT Forecast FAQ

Is Fulgent Genetics stock a buy?

Fulgent Genetics stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Fulgent Genetics is a favorable investment for most analysts.

What is Fulgent Genetics's price target?

Fulgent Genetics's price target, set by 2 Wall Street analysts, averages $45 over the next 12 months. The price target range spans from $40 at the low end to $50 at the high end, suggesting a potential 167.06% change from the previous close price of $16.85.

How does Fulgent Genetics stock forecast compare to the average forecast of its sector, industry, and investment themes?

Fulgent Genetics stock forecast shows a 167.06% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for Fulgent Genetics over the past three months?

  • January 2025: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 33.33% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 20.00% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is Fulgent Genetics’s EPS forecast?

Fulgent Genetics's average annual EPS forecast for its fiscal year ending in December is 0.33 for 2024, a -105.86% decrease from the reported $-5.63 in 2023. The prediction for 2025 is $-0.15, and $0.03 for 2026.

What is Fulgent Genetics’s revenue forecast?

Fulgent Genetics's average annual revenue forecast for its fiscal year ending in December is $281.98M for 2024, a -2.50% decrease from the reported $289.21M in 2023. The forecast for 2025 is $324.65M, and $365.32M for 2026.

What is Fulgent Genetics’s net income forecast?

For its fiscal year ending in December, Fulgent Genetics's average annual net income forecast is $9.55M for 2024, reflecting a -105.69% decrease from the reported $-168M in 2023. The projection for 2025 is $-4.585M, and $784K for 2026.